NEW YORK , July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Embecta Corp. (NASDAQ: EMBC).
A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its...
LOS ANGELES , July 16, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz  announces that investors with losses related to Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC ) have...
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and...
Wall Street Turned Bearish on Embecta After a "Major Miss" Exposed the Gap Between Management's "Incredibly Resolute" Pen Needle Claims and a 57.8% Single-Day Stock Collapse
Embecta Promised Investors Flat-to-Down-2% Revenue and $2.80–$3.00 EPS — Then Delivered a 17.4% Revenue Collapse and Slashed Earnings Guidance by Nearly Half
NEW YORK , July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised...
SAN FRANCISCO , July 16, 2026 /PRNewswire/ -- Embecta Corp. ( NASDAQ: EMBC ) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common...
A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin...
Important Notice Regarding Alleged Pen Needle Revenue Misrepresentations That Cost Embecta Investors Over 57% of Share Value